MetaCap

Cumberland Pharmaceuticals (CPIX) vs Retension Pharmaceuticals (RTSN)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Cumberland Pharmaceuticals is the larger company by market cap ($87.6 million vs $87.6 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CPIX-16.93%RTSN-0.19%
+60%+8%-45%
Oct 9, 20261 yearNov 20, 2026
CPIX-16.93%RTSN-0.19%
+49%+6%-37%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CPIX versus RTSN key metrics
MetricCPIXRTSN
Share price$5.84$10.51
Market cap$87.57M$87.57M
1-day change-7.30%-19.22%
YTD return+46.73%—
1-year return+193.47%—
5-year return+161.88%—
Forward P/E41.71—
EPS (TTM)$-0.57$-2.61
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$44.52M—
Revenue growth (YoY)+17.57%—
Net income (latest FY)$-2.84M—
Gross margin85.02%—
Operating margin-6.27%—
Net margin-6.37%—
52-week high$9.28$18.64
52-week low$2.00$9.23
Distance from 52-week high-37.07%-43.62%
Analyst consensus—strong_buy
Avg. price target upside—+391.63%
Average volume114.52K144.93K
Shares outstanding15.00M8.33M
Employees8812
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Cumberland Pharmaceuticals

CPIX stock →

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H.

Health Care · Biotechnology: Pharmaceutical Preparations · 88 employees

About Retension Pharmaceuticals

RTSN stock →

Retension Pharmaceuticals, Inc. operates as a clinical -stage biopharmaceutical company focused on developing medicines for the treatment of hypertension and other cardiovascular diseases.

Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees

CPIX vs RTSN FAQ

Which is bigger, Cumberland Pharmaceuticals or Retension Pharmaceuticals?

Cumberland Pharmaceuticals (CPIX) is larger, with a market capitalization of $87.57M compared with $87.57M for Retension Pharmaceuticals (RTSN).

Are Cumberland Pharmaceuticals and Retension Pharmaceuticals in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons